Idenix Pharmaceuticals to Present at Deutsche Bank's 2008 Biotech Boston Confab
November 10 2008 - 8:30AM
PR Newswire (US)
CAMBRIDGE, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that management
will present at Deutsche Bank's 2008 Biotech Boston Confab on
Tuesday, November 11th at 9:40 a.m. ET. The live and archived
webcast of the presentation can be accessed under "Calendar of
Events" in the Idenix Investor Center at http://www.idenix.com/.
Please log in approximately 5-10 minutes before the event to ensure
a timely connection. The archived replay will be available on the
Idenix website for two weeks following the conference. About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts, is a biopharmaceutical company engaged in the
discovery and development of drugs for the treatment of human viral
and other infectious diseases. Idenix's current focus is on the
treatment of infections caused by the hepatitis C virus and HIV.
For further information about Idenix, please refer to
http://www.idenix.com/. Idenix Pharmaceuticals' Contacts: Media:
Teri Dahlman (617) 995-9905 Investors: Amy Sullivan (617) 995-9838
DATASOURCE: Idenix Pharmaceuticals, Inc. CONTACT: Media, Teri
Dahlman, +1-617-995-9905, or Investors, Amy Sullivan,
+1-617-995-9838, both of Idenix Pharmaceuticals, Inc. Web site:
http://www.idenix.com/
Copyright
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024